Abstract

Introduction: The PREDICT study confirmed that the spot sign was a valid predictor of expansion in intracerebral hemorrhage (ICH) at 24h, with a positive predictive value (PPV) of 61%. This technique requires access to computed tomography angiography (CTA). Other markers may enhance the ability to predict expansion in ICH, or be useful in cases where multimodal imaging is not available. Previous studies have suggested that markers on non-contrast computed tomography (NCCT) such as density heterogeneity within the hematoma, irregularity of external margins, or internal fluid levels are associated with hematoma expansion (HE). Methods: Baseline NCCT scans of patients enrolled in PREDICT were examined for the presence of internal fluid levels (defined as a change within the hematoma resulting in a linear interface between two discrete fluid densities) and for the presence of hematoma density heterogeneity and margin irregularity (using an ordinal scale of 1-5 defined, published and validated previously). The association of each marker with median 24h absolute growth and with significant HE (defined as an increase in hematoma size of 6 mL or 33% measured 24h from baseline) were determined. Results: Fluid levels were present in 29 (8.3%) of 351 eligible patients. The presence of fluid levels were associated with significant HE at 24h (χ2 =7.64, df=1, p<0.01) and with a trend toward increased median absolute ICH volume at 24h (6.4 mL vs. 0.9 mL, p=0.09). The PPV for fluid levels was 52% (95% CI 46-57) for significant HE. Increased density heterogeneity (p<0.01) and margin irregularity (p<0.01) were both associated with increased median absolute ICH volume at 24h. Increased density heterogeneity was associated with significant HE (χ2 =20.0, df=4, p<0.01); increased margin irregularity had a trend toward association with significant HE (χ2 =8.69, df=4, p=0.06). Conclusions: Density heterogeneity and fluid levels are associated with significant HE at 24h, and margin irregularity is associated with increased median hematoma size. These markers may be useful for predicting significant HE in ICH in cases where CTA is unavailable to identify the presence of a spot sign. They may also provide additional variables to incorporate into risk scores for hematoma expansion.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.